甲状腺激素配置和病之间的相关性:改善全球结果 (KDIGO) 糖尿病病患者的风险类别
Kashif Abdullah1,2, Anjum Shahzad2,3, Seemab Javaid4
1Nephrology, Chelsea and Westminster Hospital NHS Foundation Trust, London, GBR.
Cureus
|May 7, 2025
概括
甲状腺功能障碍与糖尿病病 (DKD) 的恶化有关. 随着病风险的增加,甲状腺激素水平发生变化,与功能标志物相关联.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 内部医学 内部医学
背景情况:
- 甲状腺功能障碍在糖尿病病 (DKD) 中很普遍,可能会影响其进展.
- 调查甲状腺激素配置文件与DKD严重程度之间的联系对于患者管理至关重要.
研究的目的:
- 为了检查甲状腺激素水平 (FT3,FT4,TSH) 和病之间的关系:改善整体结果 (KDIGO) 在DKD患者的风险分层.
主要方法:
- 一项横截面研究分析了350名DKD患者,评估了甲状腺激素,eGFR,ACR,肌素,HbA1c和糖尿病持续时间.
- 患者被分为KDIGO风险类别.
主要成果:
- 甲状腺功能障碍的患病率随着KDIGO风险的增加而增加 (p=0.005).
- 自由三甲状腺素 (FT3) 和自由甲状腺素 (FT4) 水平下降,而甲状腺刺激激素 (TSH) 增加,导致KDIGO风险更高.
- FT3和FT4与eGFR,ACR和肌素有显著的相关性,表明晚期DKD中甲状腺功能发生改变.
结论:
- 甲状腺功能障碍与DKD严重程度密切相关.
- 甲状腺激素配置文件与关键的脏标记物相关,这表明它们在监测DKD进展和功能方面的潜在作用.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
483
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
483
Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Renal Failure: Dose Adjustments
37
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Insulin: Dosing Regimen and Adverse Effects
127
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
127
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K


